- Home
- NXTS vs EVGN Comparison
NXTS vs EVGN Comparison
Compare NXTS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXTS | EVGN |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | Israel | Israel |
| Employees | 9 | N/A |
| Industry | Agricultural Chemicals | Agricultural Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 5.3M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | NXTS | EVGN |
|---|---|---|
| Price | $2.64 | $0.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | ★ 2.4M | 1.0M |
| Earning Date | 05-16-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.37 |
| 52 Week High | $23.80 | $1.50 |
Technical Indicators
Market Signals| Indicator | NXTS | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 44.33 |
| Support Level | $0.55 | $0.37 |
| Resistance Level | $6.40 | $1.23 |
| Average True Range (ATR) | 0.51 | 0.05 |
| MACD | -0.28 | 0.01 |
| Stochastic Oscillator | 0.26 | 60.40 |
Price Performance
Historical ComparisonAbout NXTS Nexentis Technologies Inc. Common Stock
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.